A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy

Journal of Neurology

Volumn 249, Issue 10, 2002, Pages 1370-1377

  Comi, Giancarlo ⁱ   Roveri, Luisa ⁱ   Swan, Antony ^a   Willison, Hugh ^b   Bojar, Martin ^c   Illa, Isabel ^d   Karageorgiou, Clementine ^e   Nobile Orazio, Eduardo ^f   Van den Bergh, Peter ^g   Swan, Tony ^h   Hughes, Richard ^h  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c CHARLES UNIVERSITY   (Czech Republic)

^d HOSPITAL CLÍNIC   (Spain)

^e KAT HOSPITAL   (Greece)

^f UNIVERSITY OF MILAN   (Italy)

^g CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^h GUY S HOSPITAL   (United Kingdom)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Intravenous immunoglobulin; Paraproteinaemic demyelinating neuropathy

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN M; PARAPROTEIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMYELINATING NEUROPATHY; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DYSPEPSIA; FEMALE; FEVER; GRIP STRENGTH; HEADACHE; HUMAN; MALE; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; OUTCOMES RESEARCH; PARAPROTEINEMIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SENSORY SYSTEM; SYMPTOM; TREATMENT OUTCOME; WALKING SPEED;

AGED; CROSS-OVER STUDIES; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PARAPROTEINEMIAS; POLYRADICULONEUROPATHY; TREATMENT OUTCOME;

EID: 18644363004     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0808-z     Document Type: Article

References (44)

1. Bamford JM, Sandercock PA, Warlow CP, Slattery J (1989) Interobserver agreement for the assessment of handicap in stroke patients (letter). Stroke 20 (6): 828
2. Blume G, Pestronk A, Goodnough LT (1995) Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide. Neurology 45: 1577-1580
3. Braun PE, Frail DE, Latov N (1982) Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem 39: 1261-1265
4. Chou DKH, Ilyas AA, Evans JE, et al. (1985) Structure of glycolipid reacting with monoclonal IgM in neuropathy and HNK1. Biochem Biophys Res Commun 128: 283
5. Cook D, Dalakas M, Galdi A, Biondi D, Porter H (1990) High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy. Neurology 40: 212-214
6. Dalakas MC, Quarles RH, Farrer RG, Dambrosia J, et al. (1996) A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 40: 792-795
7. Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51 (Suppl 5): S2-S8
8. Dietrich G, Kazatchkine MD (1990) Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contains anti-idiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest 85: 620-629
9. Dyck PJ, Low PA, Windebank AJ, et al. (1991) Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 325: 1842-1846
10. Ellie E, Vital A, Steck A, Boiron JM, Vital C, Julien J (1996) Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases. J Neurol 243: 34-43
11. Gabriel JM, Erne B, Miescher Prof. Giancarlo Comi, Miller SL, Vital A, Vital C, Steck A (1996) Selective loss of myelin associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy. Brain 119: 775-787
12. Goodkin DE, Hertsgaard D, Seminary J (1988) Upper extremity function in multiple sclerosis: improving assessment sensitivity with block-and-box and nine-hole peg tests. Arch Phys Med Rehabil 69 (10): 850-854
13. Gorson KC, Allam G, Ropper AH (1997) Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48: 321-328
14. Gosselin S, Kyle R, Dyck P (1991) Neuropathy associated with monoclonal gammapathies of undetermined significance. Ann Neurol 30: 54-61
15. Haas DC, Tatum AH (1988) Plasma-pheresis alleviate neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia. Ann Neurol 23: 394-296
16. Hays AP, Latov N, Takatsu M, Sherman WH (1987) Experimental demyelination of nerve induced by serum of patients with neuropathy and anti-MAG IgM M-proteins. Neurology 37: 242-256
17. Hoang-Xuan K, Legér JM, Ben-Younes-Chennoufi A, Saidi H, Bouche P, Baumann N, Brunet P (1993) Traitment des neuropathies dysimmunitaires par immunoglobulines polyvaalentes intraveineuses. Rev Neurol (Paris) 149: 385-392
18. Hughes RAC, Bensa S, Willison H, van den Bergh P, Comi, G, et al. (2001) Randomised controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50: 195-201
19. Ilyas AA, Cook SD, Dalakas MC, Mitchen FA (1992) Anti-MAG IgM paraprotein from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide. J Neuroimmunol 37: 85-92
20. Ilyas AA, Willison HJ, Dalakas MC, Whittaker JN, Quarles RH (1988) Identification and characterisation of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. J Neurochem 51: 851-858
21. Jauberteau MO, Henin D, Bouche P, et al. (1988) Etude des anticorps anti-glycolipides au cours des dysglobulinémies monoclonales à IgM associées à une neuropathie périphérique. Rev Neurol (Paris) 144: 474-480
22. Jenkinson C, Coulter A, Wright L (1993) Short form 36 (SF36) health survey questionnaire: normative data for adults of working age (see comments). Brit Med J 306(6980): 1437-1440
23. Karen DF, Warren JS, Lowe JB (1988) Strategy to diagnose monoclonal gammopathies in serum: high-resolution electrophoresis, immunofixation, and k/l quantification. Clin Chem 34: 2196-2201
24. Kleyweg RP, van der Meché FGA, Schmitz PIM (1991) Intraobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14: 1103-1109
25. Kurlander RJ (1980) Reversible and irreversible loss of Fc receptor function of human monocytes as a consequence of interaction with immunoglobulin G J Clin Invest 66: 773-781
26. Latov N (1987) Waldenstrom's macroglobulinemia and non malignant IgM monoclonal gammapathies. In: Kelly JJ, Kyle RA, Latov N (eds) Polyneuropathies associated with plasma cell dyscrasia. Boston: Martinus Nijhoff, pp 51-72
27. Lecky BRF (ed) (1994) Gammaglobulin treatment in Neurology. Fundamentals and clinical applications. J Neurol Neurosurg Psychiatry 57 (Suppl 1)
28. Legér JM, Ben Younes-Chennoufi A, Chassnde B, et al. (1995) Treatment with human immunoglobulin of multifocal motor neuropathy and of polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry 57 (Suppl): 46-49
29. Mariette X, Chastang C, Clavelou P, Louboutin JP, Legér JM, Brouet JC, for the IgM-associated Polyneuropathy Study Group (1997) A randomised clinical trial comparing interferon-a and intravenous immunoglobulin in polyneuropathy associate with monoclonal IgM. J Neurol Neurosurg Psychiatry 63: 28-34
30. Martina IS, Van Koningsveld R, Schmitz PI, van der Meche FG, van Doorn PA (1998) Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group. J Neurol Neurosurg Psychiatry 65 (5): 743-747
31. Merkies ISJ, Schmitz PIM, van der Meché FGA, van Doorn PA for the Inflammatory Neuropathy Cause and Treatment (INCAT) Group (2000) Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Neurology 54: 943-949
32. Merkies ISJ (2001) Evaluation of scales and measurement instruments in immune-mediated neuropathies. PhD Thesis, Erasmus University, Rotterdam
33. Notermans NC, Lokhorst HM, Franssen H, van der Graaf Y, Teunissen LL, Jennekens FGI, et al. (1996) Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance. Neurology 47: 1227-1233
34. Notermans NC, Wokke JHJ, Lokhorst HM, Franssen H, van der Graaf Y, Jennekens FGI (1994) Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities. Brain 117: 1385-1393
35. Oksenhendler E, Chevret S, Léger JM, Louboutin JP, Bussel A, Brouet Jc for the IgM-Associated Polyneuropathy Study Group (1995) Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. J Neurol Neurosurg Psychiatry 59: 243-247
36. Senn SJ (1993) Cross-over Trials in Clinical Research. Chichester: Wiley
37. Sherman WH, Olaarte MR, McKieman G, Sweeney K, Latov N, Hays AP (1984) Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. Neurol Neurosurg Psychiatry 47: 813-819
38. Simmons Z, Albers JW, Bromberg MB, Feldman EL (1995) Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 118: 359-368
39. Smith IS (1994) The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinemia: a clinical and neurophysiological study. Brain 11: 949-957
40. Suarez GA, Kelly JJ (1993) Polyneuropathy associated with monoclonal gammapathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology 43: 1304-1308
41. Tatum AH (1993) Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol 3: 502-506
42. Uher F, Dickler HB (1986) Cooperativity between B lymphocytes membrane molecules: independent ligand occupancy and cross-linking of antigen receptors and Fc gamma receptors down-regulates B lymphocytes function. J Immunol 137: 3124-3129
43. van Doorn PA, Brand A, Strengers PFW, Meulstee J, Vermeulen M (1990) High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study (see comments). Neurology 40: 209-212
44. Yeung KB, Thomas PK, King RKM, et al. (1991) The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. J Neurol 238: 383-391